Internal Medicine, Rheumatology · Catonsville, MD
NPI
1861783243
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
700 Geipe Road, Suite 200
Catonsville, MD, 21228
Phone (410) 744-0661
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
125,940 services
Medicare patients, 2024
445
Average age 72
Drug cost, 2024
$3.6M
2,049 prescriptions
Company payments, 2025
$2,256
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ebrahim Talebi Quje was code J1306 (injection, inclisiran, 1 mg), 8,520 times for 15 patients. In total Ebrahim Talebi Quje billed 125,940 services in 75 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 8,520 | 15 | $9.51 | $81K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,039 | 41 | $0.10 | $389 |
| J0897 Injection, denosumab, 1 mg | Office | 3,121 | 36 | $20.64 | $64K |
| 99214 Office E&M - Established | Office | 665 | 302 | $90.53 | $60K |
| 36415 Venipuncture Blood Collection | Office | 658 | 303 | $4.81 | $3,166 |
| 80053 Clinical Chemistry | Office | 591 | 272 | $10.25 | $6,059 |
| 85025 Blood Count | Office | 545 | 256 | $7.54 | $4,112 |
| 86140 Clinical Chemistry | Office | 542 | 257 | $5.03 | $2,724 |
| 85652 Clinical Chemistry | Office | 500 | 235 | $2.62 | $1,310 |
| 86235 Immunoassay | Office | 481 | 60 | $17.03 | $8,190 |
| 99213 Office E&M - Established | Office | 298 | 136 | $66.71 | $20K |
| 96413 Chemotherapy Administration | Office | 262 | 45 | $105.99 | $28K |
| 96401 Chemotherapy Administration | Office | 209 | 39 | $57.38 | $12K |
| 20611 Joint Injection | Office | 201 | 70 | $87.17 | $18K |
| 86147 Immunoassay | Office | 181 | 60 | $24.58 | $4,449 |
By year: 2022 $963K for 39,687 services; 2023 $1.5M for 51,044 services; 2024 $1.5M for 125,940 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 658 | 303 | $4.81 | $3,166 |
| 80053 Clinical Chemistry | 591 | 272 | $10.25 | $6,059 |
| 85025 Blood Count | 545 | 256 | $7.54 | $4,112 |
| 86140 Clinical Chemistry | 542 | 257 | $5.03 | $2,724 |
| 85652 Clinical Chemistry | 500 | 235 | $2.62 | $1,310 |
| 86235 Immunoassay | 481 | 60 | $17.03 | $8,190 |
| 86147 Immunoassay | 181 | 60 | $24.58 | $4,449 |
| 86146 Immunoassay | 177 | 59 | $24.57 | $4,350 |
| 86160 Immunoassay | 147 | 58 | $11.45 | $1,684 |
| 83516 Immunoassay | 140 | 69 | $11.01 | $1,542 |
Medicare prescription drug claims, 2024
In 2024, the drug Ebrahim Talebi Quje prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 387 prescriptions and refills. In total Ebrahim Talebi Quje wrote 2,049 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 387 | 1,055 | 138 | $25K |
| Methotrexate Methotrexate Sodium | 216 | 459 | 57 | $6,896 |
| Prednisone Generic | 199 | 360 | 76 | $1,314 |
| Gabapentin Generic | 119 | 191 | 46 | $2,063 |
| Enbrel Mini Etanercept | 108 | 114 | 14 | $867K |
| Sulfasalazine Generic | 102 | 193 | 28 | $2,891 |
| Leflunomide Generic | 88 | 205 | 35 | $4,819 |
| Duloxetine Hcl Generic | 68 | 143 | 28 | $2,454 |
| Cyclobenzaprine Hcl Generic | 58 | 60 | 19 | $654 |
| Humira(Cf) Pen Adalimumab | 52 | 58 | Under 11 | $390K |
| Tramadol Hcl Generic | 50 | 50 | 11 | $415 |
| Tizanidine Hcl Generic | 46 | 76 | 15 | $511 |
| Pregabalin Generic | 46 | 65 | 11 | $711 |
| Allopurinol Generic | 38 | 106 | 14 | $541 |
| Cimzia (2 Pack) Certolizumab Pegol | 38 | 45 | Under 11 | $287K |
Brand drugs: - claims; generic drugs: 1,514 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ebrahim Talebi Quje $2,256 ($2,256 in general payments such as food, travel and fees) from 14 companies. The largest payer was UCB, Inc. with $493.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 21 | $493 |
| Abbvie Inc. ABBV | 19 | $399 |
| Amgen Inc. AMGN | 13 | $303 |
| Janssen Biotech, Inc. JNJ | 6 | $247 |
| GlaxoSmithKline, LLC. GSK | 7 | $156 |
| Pfizer Inc. PFE | 6 | $145 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $144 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $99.16 |
| Mallinckrodt Hospital Products Inc. | 3 | $73.29 |
| Octapharma USA, Inc. | 3 | $67.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.